Key regions: United Kingdom, Canada, Japan, Europe, China
The demand for dermatological drugs in Gabon has been on the rise in recent years.
Customer preferences: Gabon has a tropical climate, which makes the country prone to various skin conditions such as acne, eczema, and fungal infections. As a result, there is a high demand for dermatological drugs in the country. Customers in Gabon prefer dermatological drugs that are effective in treating skin conditions and are affordable.
Trends in the market: The dermatological drugs market in Gabon is growing at a steady pace due to the increasing prevalence of skin diseases. The market is dominated by topical drugs such as creams, ointments, and gels, which are easy to use and have fewer side effects compared to oral drugs. The demand for dermatological drugs is expected to increase in the coming years due to the growing awareness about skin health and the availability of a wide range of products in the market.
Local special circumstances: Gabon has a small population and a relatively small market for dermatological drugs. However, the country has a high incidence of skin diseases due to its tropical climate. This presents an opportunity for pharmaceutical companies to develop and market dermatological drugs that are specifically tailored to the needs of the Gabonese population. Additionally, the government of Gabon has taken steps to improve the healthcare system in the country, which is expected to drive the demand for dermatological drugs in the coming years.
Underlying macroeconomic factors: Gabon is a middle-income country with a growing economy. The country has a small pharmaceutical industry, and most of the drugs are imported. The government of Gabon has implemented policies to encourage local production of drugs, which is expected to boost the pharmaceutical industry in the country. Additionally, the government has invested in healthcare infrastructure, which is expected to increase access to healthcare services, including dermatological drugs. The growing economy and improving healthcare system are expected to drive the demand for dermatological drugs in Gabon in the coming years.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
